Below are the earnings highlights for Emergent BioSolutions Inc (EBS):
Earnings: -$31.3 million in Q4 vs. -$49.5 million in the same period last year.
EPS: -$0.58 in Q4 vs. -$0.95 in the same period last year.
Excluding items, Emergent BioSolutions Inc reported adjusted earnings of $2.6 million or $0.05 per share for the period.
Revenue: $194.7 million in Q4 vs. $276.6 million in the same period last year.
For comments and feedback: editorial@rttnews.com